Clinical Trial Update: Glucagon Enhanced Insulin Absorption in Diabetes Mellitus Type 1 [Phase 2]

View source ↗

Summary

This update notes the termination of a Phase 2 clinical trial evaluating glucagon-enhanced insulin absorption in individuals with Type 1 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• GLUCAGON (GLUCAGON)
• Insulin (insulin)

Snippet

Sponsor: St. Olavs Hospital | Conditions: Type 1 Diabetes | Phase 2 | Status: TERMINATED